Intradermal challenge with interleukin-8 causes tissue oedema and neutrophil accumulation in atopic and non-atopic human subjects

Clinical and Experimental Allergy

Volumn 26, Issue 12, 1996, Pages 1371-1379

  Douglass, J ^a,c   Dhami, D ^a   Bulpitt, M ^a   Lindley, I J ^b   Shute, J ^a   Church, M K ^a   Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Chemotaxis; Eosinophil; Human skin; Interleukin 8; Intradermal challenge; Lymphocyte; Neutrophil

Indexed keywords

HISTAMINE; INTERLEUKIN 8;

ADULT; ARTICLE; ATOPY; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; EOSINOPHIL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOCYTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLERGENS; CAPILLARY PERMEABILITY; CHEMOTAXIS, LEUKOCYTE; EDEMA; EOSINOPHILS; HISTAMINE; HUMANS; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRADERMAL; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECOMBINANT PROTEINS; SKIN DISEASES; T-LYMPHOCYTES;

EID: 0030475627     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00538.x     Document Type: Article

References (47)

1. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992; 82:273-5.
2. Van Zee K, De Forge L, Fischer E, Marano M, Kenrey J, Remick D, Leury S, Moldawer L. IL-8 in septic shock, endotoxaemia and after IL-1 administration. J Immunol 1991; 146:3478-82.
3. Millar A, Brown Z, Spiteri M, Westwick J. Interleukin-8 (IL-8) is produced by the bronchoalveolar lavage cell population from patients with active but not inactive sarcoidosis. Am Rev Respir Dis 1992; 145 (Suppl.):A231.
4. Assadullahi TP, Church MK, Dai Y et al. Interleukin-8 concentrations are elevated in children with cystic fibrosis(CF). Am Rev Resp Dis 1992; 145 (Suppl.):A118
5. Donnelly SC, Streiter RM, Kunkel SL et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-7.
6. Redington AE, Bradding P, Douglass JA et al. Bronchial epithelial cytokine production in asthmatics and non-asthmatics. Thorax 1993; 48:1081 (abstr).
7. Kunkel SL, Standiford T, Kasahara K, Stricter RM. Interleukin-8 (IL-8); the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17:17-23.
8. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9:617-48.
9. Matsushima K, Morishita K, Yoshimura T et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 1988; 167:1883-93.
10. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 1990; 144:2205-10.
11. Detmers PA, Lo SK, Olsen-Egbert E et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990; 171:1155-62.
12. Paccaud J-P, Schifferli JA, Baggiolini M. NAP-1/IL-8 induces up-regulation of CR1 receptors on human neutrophil leukocytes. Biochem Biophys Res Commun 1990; 166:187-92.
13. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9:617-48.
14. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating peptide (NAP-1) is also chemotactic for T-lymphocytes. Science 1989; 243:1464-6.
15. Dahinden CA, Kurimoto Y, De Week A et al. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. J Exp Med 1989; 170:1787-92.
16. Warringa RAJ, Koenderman L, Kok PTM, Kreukniet J, Bruijnzeel PLB. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991; 77:2694-700.
17. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993;23:1027-36.
18. Schroder J-M, Sticherling M, Henniecke HH, Preissner WC, Christophers E. IL-1α or tumor necrosis factor-α stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990. 144:2223-32.
19. Braun RK, Franchini M, Erard F et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 1993; 23:956-60.
20. Moller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993; 151:3261-6.
21. Michel G, Kemeny L, Peter RU et al. Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS-Lett. 1992; 305: 241-3.
22. Wang JM, Taraboletti G, Matsushima K, VanDamme J, Mantovani A. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Comm 1990; 169:165-70.
23. Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 1993; 129:74-80.
24. Camp RDR, Fincham NJ, Ross JS, Bacon KB, Grearing AJH. Leukocyte chemoattractant cytokines of the epidermis. J Invest Dermatol 1990; 95:108S-110S.
25. Griffiths CEM, Barker JNWN, Kunkel S, Nickoloff BJ. Modulation of leukocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol 1991; 124:519-26.
26. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989; 134:755-60.
27. Rampart M, Van Damme J, Zonnekeyn L, Herman AG. Granulocyte chemotactic protein interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989; 135:21-5.
28. Medhurst AD, Westwick J, Piper PJ. hr IL-8-induced responsiveness in guinea pig perfused lungs. Ann NY Acad. Sci 1991; 629:419-20.
29. Douglass JA, Dhami D, Gurr CE et al. Influence of interleukin-8 challenge in the nasal mucosa in atopic and non-atopic subjects. Am J Respir Crit Care Med 1994; 150:1108-13
30. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M. Neutrophil recruitment by intradermally injected neutrophil attractant activation protein-1. J Invest Dermatol 1991; 96:690-4
31. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L. Upregulation of formly-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immun 1993; 91:1198-1205.
32. Lindley I, Aschauer H, Seifert J-M et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor: Proc. Natl. Acad. Sci 1988; 85:9199-203.
33. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176:1381-6.
34. Tai PC, Spry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984; 309:182-4.
35. Dewald B, Rindler-Ludwig R, Bretz UC, Baggiolini M. Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes. J Exp Med 1975; 141:709-23.
36. Foster SJ, Aked DM, Schroder J-M, Christophers E. Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology 1989; 67:181-3.
37. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet a granule membrane protein, is also synthesized by vascular endothelial cells and is localised in Weibel-Palade bodies. J Clin Invest 1989; 1984:92-9.
38. Leonard EJ, Yoshimura T, Tanaka S, Raffield M. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol 1991; 96:690-4.
39. Dahinden CA, Kurimoto J, Baggiolini M, Dewald B, Walz A. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil activating peptide NAF. Int Arch Allergy Appl Immunol 1989; 90:113-8.
40. Swensson O, Schubert C, Christophers E, Schroder J-M. Inflammatory properties of neutrophil-activating protein-1/ interleukin-8 (NAP-1/IL-8) in human skin: a light and electron microscopic study. J Invest Dermatol 1991; 96:682-9.
41. Ribiero RA, Flores CA, Cunha RQ, Ferrereira SH. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 1991; 73:472-7.
42. Villar MTA, Douglass J, Shute J, Church MK, Holgate ST. Interleukin-8 is a chemoattractant for eosinophils primed with interleukin-4. Am Rev Respir Dis 1993; 147:A242(abstr).
43. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to IL-8. Proc Natl Acad Sci USA 1993; 90:7158-62.
44. Gearing AJH, Fincham NJ, Bird CR et al. Cytokines in skin lesions of psoriasis. Cytokine 1990; 2:68-75.
45. Griffiths CEM, Barker JNWN, Kunkel S, Nickoloff BJ. Modulation of leucocyte adhesion molecules, a T-cell chemoataxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol 1991; 124:519-26.
46. Ansel J, Perry P, Brown J et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990; 94:101S-107S.
47. Mielke V, Bauman JG, Sticherling M et al. Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1α- and human recombinant tumor necrosis factor-α-stimulated human dermal fibroblasts. J Immunol 1990; 144:153-61.